These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 19550287

  • 21. Efficacy and safety of vitamin C vaginal tablets in the treatment of non-specific vaginitis. A randomised, double blind, placebo-controlled study.
    Petersen EE, Magnani P.
    Eur J Obstet Gynecol Reprod Biol; 2004 Nov 10; 117(1):70-5. PubMed ID: 15474248
    [Abstract] [Full Text] [Related]

  • 22. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women.
    Simon JA, Reape KZ, Wininger S, Hait H.
    Fertil Steril; 2008 Oct 10; 90(4):1132-8. PubMed ID: 18053998
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study.
    Staskin DR, Dmochowski RR, Sand PK, Macdiarmid SA, Caramelli KE, Thomas H, Hoel G.
    J Urol; 2009 Apr 10; 181(4):1764-72. PubMed ID: 19233423
    [Abstract] [Full Text] [Related]

  • 24. The sheep as a model of preclinical safety and pharmacokinetic evaluations of candidate microbicides.
    Holt JD, Cameron D, Dias N, Holding J, Muntendam A, Oostebring F, Dreier P, Rohan L, Nuttall J.
    Antimicrob Agents Chemother; 2015 Jul 10; 59(7):3761-70. PubMed ID: 25845860
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A randomized, comparative safety study of a prefilled plastic and user-filled paper applicator with candidate microbicide tenofovir 1% gel.
    Cohen JA, Brache V, Foster J, Cochon L, Callahan M, Schwartz J.
    Sex Transm Dis; 2013 Jun 10; 40(6):476-81. PubMed ID: 23677021
    [Abstract] [Full Text] [Related]

  • 29. PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial.
    Keller MJ, Zerhouni-Layachi B, Cheshenko N, John M, Hogarty K, Kasowitz A, Goldberg CL, Wallenstein S, Profy AT, Klotman ME, Herold BC.
    J Infect Dis; 2006 Jan 01; 193(1):27-35. PubMed ID: 16323128
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviews.
    Turner AN, De Kock AE, Meehan-Ritter A, Blanchard K, Sebola MH, Hoosen AA, Coetzee N, Ellertson C.
    J Clin Epidemiol; 2009 Jul 01; 62(7):759-65. PubMed ID: 19013762
    [Abstract] [Full Text] [Related]

  • 34. Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women.
    Nel A, van Niekerk N, Kapiga S, Bekker LG, Gama C, Gill K, Kamali A, Kotze P, Louw C, Mabude Z, Miti N, Kusemererwa S, Tempelman H, Carstens H, Devlin B, Isaacs M, Malherbe M, Mans W, Nuttall J, Russell M, Ntshele S, Smit M, Solai L, Spence P, Steytler J, Windle K, Borremans M, Resseler S, Van Roey J, Parys W, Vangeneugden T, Van Baelen B, Rosenberg Z, Ring Study Team.
    N Engl J Med; 2016 Dec 01; 375(22):2133-2143. PubMed ID: 27959766
    [Abstract] [Full Text] [Related]

  • 35. PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity.
    Keller MJ, Guzman E, Hazrati E, Kasowitz A, Cheshenko N, Wallenstein S, Cole AL, Cole AM, Profy AT, Wira CR, Hogarty K, Herold BC.
    AIDS; 2007 Feb 19; 21(4):467-76. PubMed ID: 17301565
    [Abstract] [Full Text] [Related]

  • 36. Mucosal toxicity studies of a gel formulation of native pokeweed antiviral protein.
    D'Cruz OJ, Waurzyniak B, Uckun FM.
    Toxicol Pathol; 2004 Feb 19; 32(2):212-21. PubMed ID: 15200159
    [Abstract] [Full Text] [Related]

  • 37. A Phase I study of the functional performance, safety and acceptability of the BufferGel Duet.
    Ballagh SA, Brache V, Mauck C, Callahan MM, Cochon L, Wheeless A, Moench TR.
    Contraception; 2008 Feb 19; 77(2):130-7. PubMed ID: 18226678
    [Abstract] [Full Text] [Related]

  • 38. Assessment of cervicovaginal cytokine levels following exposure to microbicide Nisin gel in rabbits.
    Aranha CC, Gupta SM, Reddy KV.
    Cytokine; 2008 Jul 19; 43(1):63-70. PubMed ID: 18513989
    [Abstract] [Full Text] [Related]

  • 39. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study.
    Cano A, Estévez J, Usandizaga R, Gallo JL, Guinot M, Delgado JL, Castellanos E, Moral E, Nieto C, del Prado JM, Ferrer J.
    Menopause; 2012 Oct 19; 19(10):1130-9. PubMed ID: 22914208
    [Abstract] [Full Text] [Related]

  • 40. Safety and acceptability of 6% cellulose sulfate vaginal gel applied four times per day for 14 days.
    Doh AS, Ngoh N, Roddy R, Lai JJ, Linton K, Mauck C.
    Contraception; 2007 Sep 19; 76(3):245-9. PubMed ID: 17707724
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.